{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:41:28Z","timestamp":1784151688270,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Carbapenem antibiotics (CBPMs) may significantly reduce the serum concentration of valproic acid (VPA), but the extent of this effect among various CBPMs is unknown. This study compared the extent and onset of the interactions among ertapenem, imipenem\/cilastatin, and meropenem.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A 5-year retrospective study was performed. Hospitalized patients over 18 years old who received VPA and a CBPM concurrently were enrolled via the pharmacy computer system. Patients who lacked VPA serum concentration measurements before or during CBPMs' use, had concurrent medication(s) that might interfere with VPA metabolism, or had a history of liver cirrhosis were excluded. Total VPA serum concentrations before and during CBPMs' use and after its discontinuation were recorded, and differences among various CBPMs were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Fifty-two patients were included in this analysis. Irrespective of the route of administration, VPA serum concentrations were subtherapeutic in 90% of the subjects during CBPMs' use. There was a significant decrease (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.001) in VPA serum concentrations during the use of CBPMs: 72% \u00b1 17%, 42% \u00b1 22%, and 67% \u00b1 19% in the ertapenem (N = 9), imipenem\/cilastatin (N = 17), and meropenem (N = 26) groups, respectively. The effect of ertapenem and meropenem on VPA was significantly more expressed than that of imipenem\/cilastatin (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt; 0.005). The onset of this drug interaction occurred within 24 hours of CBPMs' administration, and VPA serum concentrations returned to 90% of baseline within 7 days of CBPMs' discontinuation along with a 20% increase in VPA dose. Increasing VPA dose during the use of ertapenem or meropenem did not result in elevating VPA serum concentrations to therapeutic levels during the combined therapy period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>CBPMs reduced VPA serum concentration within 24 hours of administration by approximately 60%. Ertapenem and meropenem had a greater effect on VPA serum concentration than imipenem\/cilastatin. Because of the dramatic reduction of VPA serum concentration during CBPMs' use, concomitant use of VPA and CBPMs should be avoided.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ftd.0000000000000316","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T12:43:05Z","timestamp":1466167385000},"page":"587-592","source":"Crossref","is-referenced-by-count":54,"title":["The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem\/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations"],"prefix":"10.1097","volume":"38","author":[{"given":"Chien-Chih","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University;"},{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Yu","family":"Pai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yuan","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University;"},{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University;"},{"name":"School of Pharmacy, College of Medicine, National Taiwan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jiuan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University;"},{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University;"},{"name":"School of Pharmacy, College of Medicine, National Taiwan University; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fe-Lin Lin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Taiwan University Hospital, College of Medicine, National Taiwan University;"},{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University;"},{"name":"School of Pharmacy, College of Medicine, National Taiwan University; and"},{"name":"National Taiwan University Cancer Center, College of Medicine, National Taiwan University, Taipei, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0090-9556(24)13678-1","article-title":"Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats","volume":"28","author":"Yamamura","year":"2000","journal-title":"Drug Metab Dispos."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/187231208786734049","article-title":"Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics","volume":"2","author":"Nakamura","year":"2008","journal-title":"Drug Metab Lett."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","article-title":"Acute seizures due to a probable interaction between valproic acid and meropenem","volume":"39","author":"Coves-Orts","year":"2005","journal-title":"Ann Pharmacother."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2710.2006.00743.x","article-title":"Epileptic seizures caused by low valproic acid levels from an interaction with meropenem","volume":"31","author":"Fudio","year":"2006","journal-title":"J Clin Pharm Ther."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","article-title":"Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study","volume":"49","author":"Haroutiunian","year":"2009","journal-title":"J Clin Pharmacol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","article-title":"Meropenem decreases serum level of valproic acid","volume":"31","author":"Nacarkucuk","year":"2004","journal-title":"Pediatr Neurol."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1345\/aph.1K079","article-title":"Interaction between valproate and meropenem: a retrospective study","volume":"41","author":"Spriet","year":"2007","journal-title":"Ann Pharmacother."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2146\/ajhp050512","article-title":"Meropenem-valproic acid interaction in patients with cefepime-associated status epilepticus","volume":"64","author":"Spriet","year":"2007","journal-title":"Am J Health Syst Pharm."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11096-013-9763-2","article-title":"Unusual drug reaction between valproate sodium and meropenem","volume":"35","author":"Yoon","year":"2013","journal-title":"Int J Clin Pharm."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1592\/phco.27.8.1202","article-title":"Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy","volume":"27","author":"Lunde","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/DMDI.2009.24.2-4.153","article-title":"Valproic acid-carbapenem interaction: report of six cases and a review of the literature","volume":"24","author":"Tobin","year":"2009","journal-title":"Drug Metabol Drug Interact."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FTD.0b013e318260f7b3","article-title":"Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases","volume":"34","author":"Park","year":"2012","journal-title":"Ther Drug Monit."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","article-title":"The effect of carbapenem antibiotics on plasma concentrations of valproic acid","volume":"43","author":"Mancl","year":"2009","journal-title":"Ann Pharmacother."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00007691-198507030-00001","article-title":"Blood-brain barrier transport of CI-912: single-passage equilibration of erythrocyte-borne drug","volume":"7","author":"Cornford","year":"1985","journal-title":"Ther Drug Monit."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.psy.44.3.255","article-title":"Six patterns of drug-drug interactions","volume":"44","author":"Armstrong","year":"2003","journal-title":"Psychosomatics"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1124\/dmd.110.034231","article-title":"Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide","volume":"38","author":"Masuo","year":"2010","journal-title":"Drug Metab Dispos."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2165\/00003495-200767070-00006","article-title":"Comparative review of the carbapenems","volume":"67","author":"Zhanel","year":"2007","journal-title":"Drugs"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1592\/phco.31.4.408","article-title":"Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations","volume":"31","author":"Miller","year":"2011","journal-title":"Pharmacotherapy"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpn.2014.12.010","article-title":"Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics?","volume":"19","author":"Miranda Herrero","year":"2015","journal-title":"Eur J Paediatr Neurol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201610000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T22:03:46Z","timestamp":1748988226000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201610000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000316","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}